Bitget App
Trade smarter
Buy cryptoMarketsTradeFuturesStocksEarnInstitutionAI & More
XLK ETF Rises 1.0%

XLK ETF Rises 1.0%

Dow JonesDow Jones2026/10/02 20:37

This article was automatically generated using Dow Jones technology.

Shares of State Street Technology Select Sector SPDR ETF rose 1.0% to $199.81 Friday on what proved to be an overall favorable trading session for the U.S. stock market, with the S&P 500 Index rising 0.7% to 7,722.72.

This was the fund's third consecutive day of gains. The fund's underlying index, the Technology Select Sector Index, rose 1.0%.

Trading volume was 8,924,483, compared to the 65-day average trading volume of 7,742,802.

As of October 1, the fund's net asset value totaled $197.83 per share.

Data source: Dow Jones Market Data, FactSet

(END) Dow Jones Newswires

October 02, 2026 16:37 ET (20:37 GMT)

0
0

Disclaimer: The content of this article solely reflects the author's opinion and does not represent the platform in any capacity. This article is not intended to serve as a reference for making investment decisions.

Understand the market, then trade.
Bitget offers one-stop trading for cryptocurrencies, stocks, and gold.
Trade now!

You may also like

Hulamin says Paul Baloyi resigns as independent non-executive director

Hulamin said independent non-executive director Paul Baloyi resigned, effective Oct. 2, 2026. Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Hulamin Ltd. published the original content used to generate this news brief via SENS, the regulatory disclosure system operated by the Johannesburg Securities Exchange (JSE) (Ref. ID: S604350), on October 05, 2026, and is solely responsible for the information contained therein.

Bitget•2026/10/05 14:30

US Stock Move | Pneumococcal vaccine achieves late-stage clinical trial target, Vaxcyte (PCVX.US) opens more than 50% higher

On Monday, Vaxcyte (PCVX.US) soared more than 50% at the open and was up approximately 53% at the time of writing, with a market capitalization of 12.8 billions USD.

智通财经•2026/10/05 13:47